Application of minimally invasive pancreatic surgery: an Italian survey.


Journal

Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 17 02 2018
accepted: 08 05 2018
pubmed: 18 5 2018
medline: 30 7 2019
entrez: 18 5 2018
Statut: ppublish

Résumé

The value of minimally invasive pancreatic surgery (MIPS) is still debated. To assess the diffusion of MIPS in Italy and identify the barriers preventing wider implementation, a questionnaire was developed under the auspices of three Scientific Societies (AISP, It-IHPBA, SICE) and was sent to the largest possible number of Italian surgeons also using the mailing list of the two main Italian Surgical Societies (SIC and ACOI). The questionnaire consisted of 25 questions assessing: centre characteristics, facilities and technologies, type of MIPS performed, surgical techniques employed and opinions on the present and future value of MIPS. Only one reply per unit was considered. Fifty-five units answered the questionnaire. While 54 units (98.2%) declared to perform MIPS, the majority of responders were not dedicated to pancreatic surgery. Twenty-five units (45.5%) performed < 20 pancreatic resections/year and 39 (70.9%) < 10 MIPS per year. Forty-nine units (89.1%) performed at least one minimally invasive (MI) distal pancreatectomy (DP), and 10 (18.2%) at least one MI pancreatoduodenectomy (PD). Robotic assistance was used in 18 units (31.7%) (14 DP, 7 PD). The major constraints limiting the diffusion of MIPS were the intrinsic difficulty of the technique and the lack of specific training. The overall value of MIPS was highly rated. Our survey illustrates the current diffusion of MIPS in Italy and underlines the great interest for this approach. Further diffusion of MIPS requires the implementation of standardized protocols of training. Creation of a prospective National Registry should also be considered.

Identifiants

pubmed: 29770922
doi: 10.1007/s13304-018-0535-3
pii: 10.1007/s13304-018-0535-3
doi:

Types de publication

Journal Article

Langues

eng

Pagination

97-103

Références

Br J Surg. 2003 Feb;90(2):171-7
pubmed: 12555292
HPB (Oxford). 2017 Mar;19(3):171-177
pubmed: 28189345
Br J Surg. 2013 Jun;100(7):917-25
pubmed: 23640668
Ann Surg. 2016 Aug;264(2):257-67
pubmed: 26863398
Ann Surg. 2015 Aug;262(2):372-7
pubmed: 26158612
J R Coll Surg Edinb. 1994 Jun;39(3):178-84
pubmed: 7932341
Br J Cancer. 2004 Aug 2;91(3):459-65
pubmed: 15226766
HPB (Oxford). 2017 Mar;19(3):190-204
pubmed: 28215904
J Am Coll Surg. 2012 Dec;215(6):810-9
pubmed: 22999327
J Clin Nurs. 2001 Sep;10(5):697-706
pubmed: 11822520
Updates Surg. 2012 Sep;64(3):179-83
pubmed: 22763577
Ann Surg. 2014 Nov;260(5):871-5; discussion 875-7
pubmed: 25243551
Updates Surg. 2017 Sep;69(3):271-283
pubmed: 28861759
JAMA Surg. 2017 Apr 1;152(4):336-342
pubmed: 28030713
HPB (Oxford). 2017 Mar;19(3):234-245
pubmed: 28190709
JSLS. 2014 Jan-Mar;18(1):14-9
pubmed: 24680137
Surg Endosc. 1994 May;8(5):408-10
pubmed: 7915434
Ann Surg. 2014 Oct;260(4):633-8; discussion 638-40
pubmed: 25203880
Ann Surg. 2019 Feb;269(2):344-350
pubmed: 29099400
Surgery. 2017 Nov;162(5):1040-1047
pubmed: 28866314
JAMA Surg. 2015 May;150(5):416-22
pubmed: 25761143
Ann Surg Oncol. 2014 Nov;21(12):4014-9
pubmed: 24923222
Ann Surg. 2007 Jul;246(1):77-82
pubmed: 17592294
Ann Surg. 2013 Oct;258(4):554-9; discussion 559-62
pubmed: 24002300
Dig Surg. 2016;33(4):299-307
pubmed: 27215422

Auteurs

Giovanni Capretti (G)

Humanitas University, Rozzano, MI, Italy.

Ugo Boggi (U)

Università di Pisa, Pisa, Italy.

Roberto Salvia (R)

Università di Verona, Verona, Italy.

Giulio Belli (G)

Ospedale Loreto Mare, Naples, Italy.

Roberto Coppola (R)

Campus Biomedico, Rome, Italy.

Massimo Falconi (M)

Università Vita Salute San Raffaele, Milan, Italy.

Andrea Valeri (A)

Ospedale Careggi, Florence, Italy.

Alessandro Zerbi (A)

Humanitas University, Rozzano, MI, Italy. alessandro.zerbi@hunimed.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH